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   Between May 1990 and April 1994, eleven patients with metastatic renal cell carcinoma received 
a combination therapy with interferon-alhpa  (IFNa) and 5-fluorouracil (5FU). IFN was admini-
stered intramuscularly six or ten million units three times per week for 4 weeks and  300  mg/m2 of 
5FU was administered by continuous intravenous infusion daily for 4 weeks. Of 8 evaluable 
patients, two had a partial response (25%) two had a minor response (25%), and two had a stable 
disease (25%). The cmmon side effects of the regimen were flu-like symptoms (91%), mucositis 
(64%) and leukopenia (75%). Three patients refused this therapy because of severe mucositis or 
stomatitis. Although the combination of IFN and 5FU in patients with metastatic renal cell car-
cinoma had some efficacy, this regimen had severe toxicity especially for the gastrointestinal (GI) 
tract. None of the patients could be administered the initially scheduled dosage of 500 mg/m2 of 
5FU. The dose limiting factor of this regimen is considered to be GI symptoms. 
                                                (Acta Urol. Jpn. 41: 517-520,1995) 



























m2を予定 して施行 したが 口内炎等の副作用が強く,
原則として300mg/m2を24時間持続で鎖骨下静脈 よ












































































































例であった.評価部位は肺が7例,対 側腎,頸 部 リソ
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